Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
37.6 NOK | 0.00% | -2.59% | -9.40% |
Apr. 30 | Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024 |
Sales 2024 * | 174M 16.33M | Sales 2025 * | 226M 21.14M | Capitalization | 580M 54.28M |
---|---|---|---|---|---|
Net income 2024 * | 7M 655K | Net income 2025 * | 13M 1.22M | EV / Sales 2024 * | 2.96 x |
Net cash position 2024 * | 63M 5.9M | Net cash position 2025 * | 65M 6.08M | EV / Sales 2025 * | 2.28 x |
P/E ratio 2024 * |
75.6
x | P/E ratio 2025 * |
42.8
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.85% |
Latest transcript on Gentian Diagnostics
1 week | -2.59% | ||
Current month | -7.84% | ||
1 month | +5.03% | ||
3 months | -7.16% | ||
6 months | -3.59% | ||
Current year | -9.40% |
Managers | Title | Age | Since |
---|---|---|---|
Njaal Kind
CEO | Chief Executive Officer | 52 | 18-01-01 |
Hilja Ibert
CHM | Chairman | - | 18-07-15 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Fredrik Thoresen
BRD | Director/Board Member | 44 | - |
Director/Board Member | 60 | - | |
Kjersti Grimsrud
BRD | Director/Board Member | 63 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 37.6 | -0.53% | 11,905 |
24-05-14 | 37.8 | 0.00% | 23,376 |
24-05-13 | 37.8 | -2.07% | 6,812 |
24-05-10 | 38.6 | 0.00% | 4,356 |
24-05-08 | 38.6 | -1.53% | 4,017 |
Real-time Oslo Bors, May 15, 2024 at 10:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.40% | 54.19M | |
-4.27% | 12.32B | |
-4.76% | 8.1B | |
+8.70% | 5.87B | |
+28.39% | 5.52B | |
-6.28% | 4.29B | |
-52.84% | 3.16B | |
+12.93% | 2.72B | |
-2.52% | 2.37B | |
+28.84% | 2.23B |
- Stock Market
- Equities
- GENT Stock